evidoria

← Back to browse

Good practice Imported

Research Contracts & Innovation (RC&I) — University of Cape Town

South Africa · Cape Town · See the South Africa profile · See the Cape Town profile

Evidence: Descriptive / self-reported Top 76% 57/100 · Ask Evidence Copilot about this practice

UCT's technology-transfer office has spun out 40 companies over 20 years, built spin-off equity worth R100M+ and now manages 2,500 research contracts worth R1.5bn+ a year — its strategy examined in peer-reviewed research alongside Stellenbosch University.

40 companies
Spin-off companies launched (2004-2024 (20 years))
50 ZAR million (more than)
Accumulated IP-commercialisation income
100 ZAR million (over)
Spin-out equity value held
178 inventions
Active inventions managed (2024)
2500 contracts (roughly)
Research contracts managed per year
1.5 ZAR billion (more than)
Annual value of research contracts managed
Research Contracts & Innovation (RC&I) — University of Cape Town Research Contracts & Innovation (RC&I) — University of Cape Town

Details

Maturity
Established
Promoter
Research Contracts & Innovation (RC&I), University of Cape Town
Period
1999–present
Keywords
university technology transfer, patent licensing, spin-off companies, research contracts

Context

Established in 1999 as the Office for Industry Liaison and renamed several times since (UCT Innovation in 2002, RCIPS in 2007, RC&I in 2016), this University of Cape Town unit protects, licenses and commercialises research IP and creates spin-off companies, supported by the Evergreen and Pre-Seed funds for early-stage ventures.

Activities

The office manages roughly 2,500 research contracts a year worth more than R1.5 billion annually, and administers 178 active inventions as of its 2024 innovation snapshot.

Results

By its 2024 innovation snapshot, UCT had launched 40 spin-off companies over 20 years, generated more than R50 million in accumulated IP-commercialisation income, and held equity in spin-outs worth over R100 million. A peer-reviewed 2014 study in Industry and Higher Education examined UCT's technology-transfer strategy alongside Stellenbosch University, finding technologies concentrated in engineering, health sciences and biotechnology were typically patented worldwide and commercialised mainly through licensing.

Conclusions

Neither the 2014 study nor UCT's own reporting breaks down how many of the 40 spin-offs remain active or profitable today.

Implementation
Indicative cost
Medium (€50k–€500k) — No specific programme operating budget disclosed; office manages R1.5bn+ in annual research-contract value and holds spin-out equity valued over R100 million.
Time to results
Long (> 3 years) — Founded 1999; renamed 2002, 2007, 2016; 2024 innovation snapshot is the latest published data point.
Staffing & skills
University technology-transfer office, renamed several times since 1999 (Office for Industry Liaison → UCT Innovation → RCIPS → RC&I)

Conditions for success

  • Dedicated Evergreen and Pre-Seed funds to bridge early-stage venture financing gaps
  • Continuous institutional operation and rebranding since 1999, preserving accumulated IP and contract-management expertise
  • Concentration on patentable domains (engineering, health sciences, biotechnology) commercialised mainly via licensing

Where it fits

Governance type
university technology-transfer office
Scale
single institution (University of Cape Town)
Income level
upper-middle-income (South Africa)

Commonly funded by

National / regional programmes

Indicative funding routes for practices of this type — always check each programme's current calls and eligibility rules.

Do you run this practice? Claim it — verified implementers get a public contact pathway and can propose corrections.

Data sources

Where this practice's information was retrieved from, and when.

Attachments

Similar practices you may find useful